A bio-analytical Remote Regulatory Assessment was also conducted from October 30 to November 7, 2025, and concluded with no observations
The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
This new facility strengthens Latin America as a collaborative hub
Expanded capabilities that continue to push the boundaries of innovation—advancing drug delivery solutions for patients, customers, and consumers around the world
Products manufactured at the new Vaughan facility will support research in areas including cancer, infectious disease, mental health, and environmental safety
Facility designed to advance the next generation of imaging systems
The company’s largest center for medical device applications, serving the entire Asian market
Insights are drawn from over 30K+ people across 300+ cities including all metro and tier-1 cities
Prof. Götz is Director of the Institute of Stem Cell Research at Helmholtz Center Munich and Chair of Physiological Genomics at Ludwig-Maximilians-Universität, Munich
Subscribe To Our Newsletter & Stay Updated
